← Leaderboards
Tohru Yamada
University Of Illinois At Chicago
$3,537,990
Attributed
$3,777,785
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $807.7K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,777,785 · 5
By mechanism
R01$2,966,711 · 3
R21$811,074 · 2
Top collaborators
- Kaori Horiguchi Yamada1 shared
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- Leon Maing Tai$6,271,259
- Tejabhiram Yadavalli$1,210,082
- Andrei L Gartel$3,460,217
- Mark Allen Sanborn$98,512
- Sarah Elizabeth Lutz$3,911,564
Others in their field
Other Emerging Leaders on “Malignant Neoplasms”
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
- Leonard Freedmand · Leidos Biomedical Research, Inc.$108,968,336
- Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
- Martha Hering · Westat, Inc.$57,098,843
Research focus
Malignant NeoplasmsCancer CellTumorPre-ClinicalNeoplasm MetastasisMalignant Breast NeoplasmMammary NeoplasmsBreast Cancer TreatmentCellsXenograft ProcedureDesignTransgenic MiceLocationSafetyAreaToxic EffectUnited States National Institutes Of HealthPreventFlexibilityBlindedMedicalExcisionDetectionImage-Guided Surgery
Grant awards (11)
Breast cancer cells secrete glycosylated protein to facilitate blood-brain barrier opening and brain metastasis$479,591
R01 · FY2025 · CA
Hypoxia-activated probiotic agents for breast cancer$328,114
R01 · FY2025 · CA · contact PI
Hypoxia-activated probiotic agents for breast cancer$346,342
R01 · FY2024 · CA · contact PI
Intraoperative Imaging for Lymph Node Metastases$213,048
R21 · FY2024 · CA · contact PI
Hypoxia-activated probiotic agents for breast cancer$380,760
R01 · FY2023 · CA · contact PI
Intraoperative Imaging for Lymph Node Metastases$186,883
R21 · FY2023 · CA · contact PI
Development of a New Fluorescent Agent for Intraoperative Image-Guided Breast Cancer Surgery$352,579
R01 · FY2021 · EB · contact PI
MicroRNA Targeted Therapeutic Approach for Pediatric High-Grade Glioma$411,143
R21 · FY2020 · CA · contact PI
Development of a New Fluorescent Agent for Intraoperative Image-Guided Breast Cancer Surgery$359,775
R01 · FY2020 · EB · contact PI
Development of a New Fluorescent Agent for Intraoperative Image-Guided Breast Cancer Surgery$359,775
R01 · FY2019 · EB · contact PI
Development of a New Fluorescent Agent for Intraoperative Image-Guided Breast Cancer Surgery$359,775
R01 · FY2018 · EB · contact PI